Pradžia › Krono liga › Ilinoisas › Chicago

Krono liga klinikiniai tyrimai Chicago, IL

9 tyrimai dėl Krono liga ieško dalyvių vietose Chicago ir aplinkui (apytiksliai 30 mylių spinduliu). Atidarykite tyrimą, kad pamatytumėte, kas gali dalyvauti ir kaip susisiekti su tyrimo komanda.

Oficialus tyrimo tekstas (anglų kalba)

Ieškote dalyvių tyrimui? Pateikite jį šio puslapio viršuje – $99 už 30 dienų →

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

Renkami dalyviai3 fazė

University of Chicago Medical Center ( Site 5066), Chicago

Amžius nuo 16 iki 80 · Visoms lytims · Atnaujinta 2026-10-02 · NCT06430801

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

Renkami dalyviai2 fazė

University of Chicago Medical Center /ID# 267400, Chicago

Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-09-25 · NCT06548542

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Renkami dalyviai3 fazė

Rush University Medical Center, Chicago

Amžius nuo 18 iki 70 · Visoms lytims · Atnaujinta 2026-09-24 · NCT06937099

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

Renkami dalyviai3 fazė

Rush University Medical Center-Site Number: 8400015, Chicago

Amžius nuo 16 iki 80 · Visoms lytims · Atnaujinta 2026-09-23 · NCT07184931

A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease

Renkami dalyviai2 fazė

Rush University Medical Center, Chicago

Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-09-22 · NCT07483073

A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease

Renkami dalyviai2 fazė

Rush University Medical Center, Chicago

Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-09-22 · NCT07483099

A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

Renkami dalyviai4 fazė

University of Chicago Medicine, Chicago

Amžius nuo 18 iki 70 · Visoms lytims · Atnaujinta 2026-09-09 · NCT06045754

Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

Renkami dalyviai

University of Chicago Medicine, Chicago

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-07 · NCT05230173

Treatment of Moderate to Severe Refractory Crohn's Disease

Renkami dalyviai1/2 fazė

Northwestern, Chicago
University of Chicago, Chicago

Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2025-12-10 · NCT06721962

Krono liga tyrimai kituose miestuose

Kiti tyrimai Chicago

Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.